These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 14506658)

  • 21. Graft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cells.
    Zhan Q; Korngold R; Lezcano C; McKeon F; Murphy GF
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):841-51. PubMed ID: 22469882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype.
    Zhan Q; Signoretti S; Whitaker-Menezes D; Friedman TM; Korngold R; Murphy GF
    J Invest Dermatol; 2007 Jan; 127(1):106-15. PubMed ID: 17039241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
    Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unraveling graft-versus-host disease and graft-versus-leukemia responses using TCR Vβ spectratype analysis in a murine bone marrow transplantation model.
    Fanning SL; Zilberberg J; Stein J; Vazzana K; Berger SA; Korngold R; Friedman TM
    J Immunol; 2013 Jan; 190(1):447-57. PubMed ID: 23203931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.
    DiRienzo CG; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):265-76. PubMed ID: 17317580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression.
    Whitaker-Menezes D; Jones SC; Friedman TM; Korngold R; Murphy GF
    Biol Blood Marrow Transplant; 2003 Sep; 9(9):559-70. PubMed ID: 14506658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target cells in graft-versus-host disease: implications for cancer therapy.
    Murphy GF
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):113-23. PubMed ID: 18094950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of selectively targeted apoptotic rete cells in graft-versus-host disease.
    Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):357-65. PubMed ID: 15148489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of TNF-α in the pathogenesis and management of GVHD.
    Levine JE
    Int J Hematol; 2011 May; 93(5):571-577. PubMed ID: 21384095
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.